Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts

被引:117
作者
Carnesecchi, S
Bras-Gonçalves, R
Bradaia, A
Zeisel, M
Gossé, F
Poupon, MF
Raul, F
机构
[1] IRCAD, INSERM, UMR S 392, Lab Nutr Oncol, F-67091 Strasbourg, France
[2] Inst Curie, CNRS, UMR 147, Lab Mol Cytol & Oncol, F-75231 Paris, France
[3] CNRS, UMR 7519, Lab Integrated Cellular Neurophysiol, Strasbourg, France
基金
澳大利亚研究理事会;
关键词
monoterpene; Caco-2; cells; TC-118; tumors; xenografts; 5-FU metabolism;
D O I
10.1016/j.canlet.2004.06.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated on colon cancer cells the effect of geraniol on thymidylate synthase and thymidine kinase expression, two enzymes related to 5-fluorouracil cytotoxicity. The anti-tumoral efficacy of geraniol and 5-fluorouracil were also evaluated on TC-118 human tumors transplanted in Swiss nu/nu mice. Geraniol (150 muM) but not 5-fluorouracil caused a 2-fold reduction of thymidylate synthase and thymidine kinase expression in cancer cells. In nude mice, the combined administration of 5-fluorouracil (20 mg/kg) and geraniol (150 mg/kg) caused a 53% reduction of the tumor volume, whereas a 26% reduction was obtained with geraniol alone, 5-fluorouracil alone showed no effect. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 21 条
  • [1] BORING CC, 1994, CA, V44, P26
  • [2] Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis
    Bras-Gonçalves, RA
    Pocard, M
    Formento, JL
    Poirson-Bichat, F
    De Pinieux, G
    Pandrea, I
    Arvelo, F
    Ronco, G
    Villa, P
    Coquelle, A
    Milano, G
    Lesuffleur, T
    Dutrillaux, B
    Poupon, MF
    [J]. GASTROENTEROLOGY, 2001, 120 (04) : 874 - 888
  • [3] Geraniol, a component of plant essential oils, sensitizes human colonic cancer cells to 5-fluorouracil treatment
    Carnesecchi, S
    Langley, K
    Exinger, F
    Gosse, F
    Raul, F
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) : 625 - 630
  • [4] Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells
    Carnesecchi, S
    Bradaia, A
    Fischer, B
    Coelho, D
    Schöller-Guinard, M
    Gosse, F
    Raul, F
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) : 711 - 715
  • [5] Carnesecchi S, 2001, J PHARMACOL EXP THER, V298, P197
  • [6] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS
    CHOU, TC
    TALALAY, P
    [J]. ADVANCES IN ENZYME REGULATION, 1984, 22 : 27 - 55
  • [7] THYMIDYLATE SYNTHASE GENE AMPLIFICATION IN HUMAN COLON-CANCER CELL-LINES RESISTANT TO 5-FLUOROURACIL
    COPUR, S
    AIBA, K
    DRAKE, JC
    ALLEGRA, CJ
    CHU, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1995, 49 (10) : 1419 - 1426
  • [8] Oxaliplatin, leucovorin and fluorouracil in pretreated patients with advanced colorectal cancer.
    deGramont, A
    Tournigand, C
    Louvet, C
    Andre, T
    Molitor, JL
    Raymond, E
    Moreau, S
    Vignoud, J
    LeBail, N
    Krulik, M
    [J]. REVUE DE MEDECINE INTERNE, 1997, 18 (10): : 769 - 775
  • [9] Antisense down-regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5-FUdR, 5-FU and Tomudex in HeLa cells
    Ferguson, PJ
    Collins, O
    Dean, NM
    DeMoor, J
    Sha-Li, C
    Vincent, MD
    Koropatnick, J
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (08) : 1777 - 1786
  • [10] New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer
    Holen, Kyle D.
    Saltz, Leonard B.
    [J]. LANCET ONCOLOGY, 2001, 2 (05) : 290 - 297